Real-time enrollment status for this obesity clinical trial
Current Status
Recruiting
Checked: August 11, 2026 at 9:00 PM UTC
| NCT Number | NCT07654361 |
| Recruiting Status | Recruiting |
| Condition | Obesity |
| Phase | PHASE3 |
| Target Enrollment | 3,600 participants |
| Active Locations | 71 sites in the US |
| Sponsor | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics |
| Last Updated on CT.gov | August 10, 2026 (Yesterday) |
As of August 11, 2026: Clinical trial NCT07654361 is currently recruiting participants. This phase3 study for obesity is actively seeking new participants at 71 locations across the United States. The study is sponsored by Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07654361 is actively recruiting participants as of August 11, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 71 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07654361 was last updated Yesterday (August 10, 2026). HelloStudys verifies this status automatically.